Diagnostic Evidence Co-operative Newcastle

The Diagnostic Evidence Co-operative Newcastle is a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.

The NIHR DEC Newcastle facilitates the generation of high quality evidence on clinical validity, utility and cost-effectiveness of in vitro diagnostic medical devices (IVDs) for use in the NHS.
For more information see About us

News & Developments

£10 million Biomedical Catalyst 2016 competition now open

A new funding boost of £57.5 million was announced for the UK’s energy and infrastructure, biomedical and quantum technology sectors by Business Secretary Sajid Javid at the first inter-ministerial group on business engagement. Click here for details of the competition and how to apply. 

£15m Stratified Medicine Initiative - call for proposals for disease-focused partnerships to stratify for patient benefit

This call aims to support consortia to address disease areas where there is a strong case for scientific advancement and major unmet clinical need. The call will maintain stratification by response to treatment but broaden the scope to include stratification by risk, diagnosis and/or prognosis. Up to £15m to fund consortia up to 5 years in duration will be available. Click here for details of the competition and how to apply. 

Postgraduate on-line learning programme in:
Clinical Health Sciences Molecular Pathology
MRC/EPSRC Newcastle Molecular Pathology Node, in conjunction with the NIHR DEC, is providing a range of on-line learning modules to enable you to gain expertise in molecular pathology and diagnostic evaluation and its relation to stratified and personalised medicine. See the flyer for more details. 

Latest IVD News